{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:01:49Z","timestamp":1789016509515,"version":"build-2803163510"},"reference-count":34,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The present study identified a novel salinomycin (Sal)-sensitization mechanism in cancer cells. We analyzed the signal proteins Akt, Jnk, p38, Jak, and Erk1\/2 in cancer cell lines that had arrested growth following low amounts of Sal treatment. We also tested the signal molecules PI3K, PDK1, GSK3\u03b2, p70S6K, mTOR, and PTEN to analyze the PI3K\/Akt\/mTOR pathway. The results showed that Sal sensitization positively correlates with large reductions in p70S6K activation. Interestingly, Akt was the only signal protein to be significantly activated by Sal treatment. The Akt activation appeared to require the PI3K pathway as its activation was abolished by the PI3K inhibitors LY294002 and wortmannin. The Akt activation by Sal was conserved in the other cell lines analyzed, which originated from other organs. Both Akt activation and C-PARP production were proportionally increased with increased doses of Sal. In addition, the increased levels of pAkt were not reduced over the time course of the experiment. Co-treatment with Akt inhibitors sensitized the Sal-treated cancer cells. The results thereby suggest that Akt activation is increased in cells that survive Sal treatment and resist the cytotoxic effect of Sal. Taken together; these results indicate that Akt activation may promote the resistance of cancer cells to Sal.<\/jats:p>","DOI":"10.3390\/ijms140917304","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T11:56:40Z","timestamp":1377172600000},"page":"17304-17318","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Low Amount of Salinomycin Greatly Increases Akt Activation, but Reduces Activated p70S6K Levels"],"prefix":"10.3390","volume":"14","author":[{"given":"Ju-Hwa","family":"Kim","sequence":"first","affiliation":[{"name":"Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do 410-769, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ae-Ran","family":"Choi","sequence":"additional","affiliation":[{"name":"Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do 410-769, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Sookmyung Women's University, Seoul 140-133, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung","family":"Kim","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungpil","family":"Yoon","sequence":"additional","affiliation":[{"name":"Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do 410-769, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.7164\/antibiotics.27.814","article-title":"Salinomycin, a new polyether antibiotic","volume":"27","author":"Miyazaki","year":"1974","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0006-291X(75)90490-8","article-title":"Salinomycin: A new monovalent cation ionophore","volume":"66","author":"Mitani","year":"1975","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dki470","article-title":"Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening","volume":"57","author":"Mahmoudi","year":"2006","journal-title":"J. Antimicrob. Chemother"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bardsley, M.R., Horvath, V.J., Asuzu, D.T., Lorincz, A., Redelman, D., Hayashi, Y., Popko, L.N., Young, D.L., Lomberk, G.A., and Urrutia, R.A. (2010). Gastroenterology, 139, 942\u2013952.","DOI":"10.1053\/j.gastro.2010.05.083"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1245\/s10434-011-1561-2","article-title":"Salinomycin selectively targets \u2018CD133+\u2019 cell subpopulations and decreases malignant traits in colorectal cancer lines","volume":"18","author":"Dong","year":"2011","journal-title":"Ann. Surg. Oncol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbrc.2009.10.042","article-title":"Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells","volume":"390","author":"Fuchs","year":"2009","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e15630","DOI":"10.1371\/journal.pone.0015630","article-title":"Markers of tumor-initiating cells predict chemoresistance in breast cancer","volume":"5","author":"Gong","year":"2010","journal-title":"PLoS One"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/bjc.2011.530","article-title":"Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress","volume":"106","author":"Ketola","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13253","DOI":"10.1073\/pnas.1110431108","article-title":"Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells","volume":"108","author":"Lu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2011.07.016","article-title":"Salinomycin inhibits osteosarcoma by targeting its tumor stem cells","volume":"311","author":"Tang","year":"2011","journal-title":"Cancer Lett"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2011.05.030","article-title":"Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells","volume":"313","author":"Zhang","year":"2011","journal-title":"Cancer Lett"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bbrc.2010.03.138","article-title":"Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells","volume":"394","author":"Fuchs","year":"2010","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10637-011-9685-6","article-title":"Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest","volume":"30","author":"Kim","year":"2012","journal-title":"Invest. New Drugs"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcmd.2010.03.008","article-title":"The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor","volume":"45","author":"Riccioni","year":"2010","journal-title":"Blood Cells Mol. Dis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1476-5381.2010.01089.x","article-title":"Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein","volume":"162","author":"Kim","year":"2011","journal-title":"Br. J. Pharmacol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2011.12.141","article-title":"Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest","volume":"418","author":"Kim","year":"2012","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1038\/sj.onc.1204083","article-title":"Development of anticancer drugs targeting the MAP kinase pathway","volume":"19","year":"2000","journal-title":"Oncogene"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/sj.onc.1207515","article-title":"Apoptosis defects and chemotherapy resistance: Molecular interaction maps and networks","volume":"23","author":"Pommier","year":"2004","journal-title":"Oncogene"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/sj.onc.1206290","article-title":"Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK\/p38 and mitochondrial death pathway","volume":"22","author":"Ohtsuka","year":"2003","journal-title":"Oncogene"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2006.10.007","article-title":"Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance","volume":"251","author":"Brozovic","year":"2007","journal-title":"Cancer Lett"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2174\/156800906778742479","article-title":"Protein kinases as drug targets in cancer","volume":"6","author":"Arslan","year":"2006","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.4161\/cc.5.8.2685","article-title":"P38 MAPK in development and cancer","volume":"5","author":"Bradham","year":"2006","journal-title":"Cell Cycle"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1038\/sj.onc.1206394","article-title":"HER2\/PI-3K\/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells","volume":"22","author":"Knuefermann","year":"2003","journal-title":"Oncogene"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/07853890600551037","article-title":"Targeting the ERK signaling pathway in cancer therapy","volume":"38","author":"Kohno","year":"2006","journal-title":"Ann. Med"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13169","DOI":"10.3390\/ijms131013169","article-title":"Lower salinomycin concentration increases apoptotic detachment in high-density cancer cells","volume":"13","author":"Kim","year":"2012","journal-title":"Int. J. Mol. Sci"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e15288","DOI":"10.1371\/journal.pone.0015288","article-title":"Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2009.07.036","article-title":"SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin","volume":"387","author":"Kim","year":"2009","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbrc.2012.01.049","article-title":"Anti-mitotic potential of 7-diethylamino-3(2\u2032-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620\/5-FU","volume":"418","author":"Kim","year":"2012","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13681","DOI":"10.1073\/pnas.251194298","article-title":"SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase","volume":"98","author":"Bennett","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11051","DOI":"10.1074\/jbc.M310256200","article-title":"Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells","volume":"279","author":"Das","year":"2004","journal-title":"J. Biol. Chem"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbrc.2006.04.005","article-title":"Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways","volume":"344","author":"Liu","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.febslet.2008.05.039","article-title":"Increased cytoplasmic levels of CIS, SOCS1, SOCS2, or SOCS3 are required for nuclear translocation","volume":"582","author":"Lee","year":"2008","journal-title":"FEBS Lett"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bcp.2009.09.008","article-title":"Jnk signaling pathway-mediated regulation of Stat3 activation is linked to the development of doxorubicin resistance in cancer cell lines","volume":"79","author":"Kim","year":"2010","journal-title":"Biochem. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/9\/17304\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:48:50Z","timestamp":1760219330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/9\/17304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,22]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9]]}},"alternative-id":["ijms140917304"],"URL":"https:\/\/doi.org\/10.3390\/ijms140917304","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,22]]}}}